Our Global Reach

Local expertise, insights, and strategies to tap into worldwide markets

We recognize the importance of delivering a consistent, evidence-supported value story. Possessing a keen understanding of access decision-making processes across major global markets, our experts help manufacturers understand the critical drivers and influencers that vary from country to country, and develop specific strategies for successful HTA submission and product access. 
Our global presence:
535+
global projects
30+
countries supported
100+
amnog dossiers
Explore our solutions

We're where you need to be.

From building brands in Brazil to strengthening support in Sweden, Xcenda has the reach to deliver insights in key markets worldwide. 
View our advisor networks

HTA Quarterly

Health technology assessment insights at your fingertips

From at-a-glance updates on important HTA decisions to reviews on what those decisions mean for specific therapeutic areas, get insights into the evolving priorities for HTAs with each complimentary edition of the HTA Quarterly. 
HTA Quarterly logo

Where to find us

Our local presence in the U.S., Canada, Germany, Switzerland, and the U.K support our clients worldwide.
See our locations

Expert consultants in Germany

Prove your product’s value through scientific rigor and local expertise of specific requirements that the German market demands.  As the leader in benefit analysis of pharmaceuticals, AMNOG dossiers, pricing and reimbursement, analysis of primary and secondary research data, health services research, health economic evaluation, as well as scientific communications, our European headquarters in Hannover, Germany is staffed by a team of economists, natural scientists, pharmacists, and methodically skilled data analysts who have a deep, working knowledge of the German market.
German flag and country outline

HTA Decision Map: Track rulings in key markets 

Stay informed on key HTA decisions to help your global strategies. Find detailed information on product decisions in Australia, Canada, France, Germany, and the United Kingdom.
View the map